25 XP   0   0   10

ALTEOGEN Inc
Buy, Hold or Sell?

Let's analyse Alteogen together

PenkeI guess you are interested in ALTEOGEN Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ALTEOGEN Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ALTEOGEN Inc

I send you an email if I find something interesting about ALTEOGEN Inc.

Quick analysis of Alteogen (30 sec.)










What can you expect buying and holding a share of Alteogen? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,857.01
Expected worth in 1 year
₩2,825.20
How sure are you?
38.9%

+ What do you gain per year?

Total Gains per Share
₩-31.80
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
₩173,700.00
Expected price per share
₩100,300 - ₩225,500
How sure are you?
50%

1. Valuation of Alteogen (5 min.)




Live pricePrice per Share (EOD)

₩173,700.00

Intrinsic Value Per Share

₩-8,938.42 - ₩-10,442.33

Total Value Per Share

₩-6,081.42 - ₩-7,585.32

2. Growth of Alteogen (5 min.)




Is Alteogen growing?

Current yearPrevious yearGrowGrow %
How rich?$103.4m$108.8m-$779.4k-0.7%

How much money is Alteogen making?

Current yearPrevious yearGrowGrow %
Making money-$590k-$1.4m$835.4k141.6%
Net Profit Margin-27.2%-39.0%--

How much money comes from the company's main activities?

3. Financial Health of Alteogen (5 min.)




What can you expect buying and holding a share of Alteogen? (5 min.)

Welcome investor! Alteogen's management wants to use your money to grow the business. In return you get a share of Alteogen.

What can you expect buying and holding a share of Alteogen?

First you should know what it really means to hold a share of Alteogen. And how you can make/lose money.

Speculation

The Price per Share of Alteogen is ₩173,700. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alteogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alteogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,857.01. Based on the TTM, the Book Value Change Per Share is ₩-7.95 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-85.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alteogen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.160.0%-0.010.0%-0.030.0%-0.010.0%-0.020.0%
Usd Book Value Change Per Share-0.170.0%-0.010.0%-0.060.0%0.010.0%0.060.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.170.0%-0.010.0%-0.060.0%0.010.0%0.060.0%
Usd Price Per Share68.95-43.61-35.23-58.20-43.01-
Price to Earnings Ratio-109.27--66.30--83.13-42.52-30.39-
Price-to-Total Gains Ratio-401.04--263.91--262.04--425.17--376.89-
Price to Book Ratio34.48-21.03-14.99-25.64-20.46-
Price-to-Total Gains Ratio-401.04--263.91--262.04--425.17--376.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share121.59
Number of shares8
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share-0.010.01
Gains per Quarter (8 shares)-0.040.06
Gains per Year (8 shares)-0.180.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-0-1000-10
20-0-1000-10
30-1-1001-10
40-1-1001-10
50-1-1001-10
60-1-1001-10
70-1-1002-10
80-1-1002-10
90-2-1002-10
100-2-1002-10

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%12.019.05.033.3%12.019.05.033.3%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%8.012.00.040.0%14.022.00.038.9%14.022.00.038.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.036.00.0%0.00.036.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%8.012.00.040.0%14.022.00.038.9%14.022.00.038.9%

Fundamentals of Alteogen

About ALTEOGEN Inc

ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; and Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.

Fundamental data was last updated by Penke on 2024-04-16 03:25:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ALTEOGEN Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alteogen earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Alteogen to the  industry mean.
  • A Net Profit Margin of -52.2% means that ₩-0.52 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ALTEOGEN Inc:

  • The MRQ is -52.2%. The company is making a huge loss. -2
  • The TTM is -27.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-52.2%TTM-27.2%-25.0%
TTM-27.2%YOY-39.0%+11.8%
TTM-27.2%5Y-30.6%+3.4%
5Y-30.6%10Y-28.2%-2.3%
1.1.2. Return on Assets

Shows how efficient Alteogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alteogen to the  industry mean.
  • -4.6% Return on Assets means that Alteogen generated ₩-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ALTEOGEN Inc:

  • The MRQ is -4.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.6%TTM-0.4%-4.1%
TTM-0.4%YOY-0.8%+0.4%
TTM-0.4%5Y-0.1%-0.3%
5Y-0.1%10Y-0.7%+0.6%
1.1.3. Return on Equity

Shows how efficient Alteogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alteogen to the  industry mean.
  • -7.9% Return on Equity means Alteogen generated ₩-0.08 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ALTEOGEN Inc:

  • The MRQ is -7.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.9%TTM-1.0%-6.9%
TTM-1.0%YOY-1.4%+0.4%
TTM-1.0%5Y0.0%-1.0%
5Y0.0%10Y-0.9%+0.8%

1.2. Operating Efficiency of ALTEOGEN Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alteogen is operating .

  • Measures how much profit Alteogen makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alteogen to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ALTEOGEN Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-13.9%+13.9%
TTM-13.9%YOY-119.2%+105.2%
TTM-13.9%5Y-55.9%+41.9%
5Y-55.9%10Y-45.8%-10.0%
1.2.2. Operating Ratio

Measures how efficient Alteogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 2.30 means that the operating costs are ₩2.30 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of ALTEOGEN Inc:

  • The MRQ is 2.301. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.107. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.301TTM2.107+0.194
TTM2.107YOY1.174+0.933
TTM2.1075Y1.384+0.723
5Y1.38410Y1.456-0.072

1.3. Liquidity of ALTEOGEN Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alteogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.43 means the company has ₩1.43 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of ALTEOGEN Inc:

  • The MRQ is 1.435. The company is just able to pay all its short-term debts.
  • The TTM is 4.118. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.435TTM4.118-2.683
TTM4.118YOY11.352-7.234
TTM4.1185Y11.145-7.027
5Y11.14510Y9.478+1.667
1.3.2. Quick Ratio

Measures if Alteogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alteogen to the  industry mean.
  • A Quick Ratio of 0.94 means the company can pay off ₩0.94 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ALTEOGEN Inc:

  • The MRQ is 0.943. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 5.477. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.943TTM5.477-4.533
TTM5.477YOY20.040-14.564
TTM5.4775Y17.304-11.828
5Y17.30410Y12.509+4.796

1.4. Solvency of ALTEOGEN Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alteogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alteogen to industry mean.
  • A Debt to Asset Ratio of 0.42 means that Alteogen assets are financed with 42.3% credit (debt) and the remaining percentage (100% - 42.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ALTEOGEN Inc:

  • The MRQ is 0.423. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.410. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.423TTM0.410+0.013
TTM0.410YOY0.387+0.023
TTM0.4105Y0.288+0.122
5Y0.28810Y0.192+0.097
1.4.2. Debt to Equity Ratio

Measures if Alteogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alteogen to the  industry mean.
  • A Debt to Equity ratio of 73.1% means that company has ₩0.73 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ALTEOGEN Inc:

  • The MRQ is 0.731. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.697. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.731TTM0.697+0.034
TTM0.697YOY0.631+0.066
TTM0.6975Y0.447+0.250
5Y0.44710Y0.295+0.151

2. Market Valuation of ALTEOGEN Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Alteogen generates.

  • Above 15 is considered overpriced but always compare Alteogen to the  industry mean.
  • A PE ratio of -109.27 means the investor is paying ₩-109.27 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ALTEOGEN Inc:

  • The EOD is -192.684. Based on the earnings, the company is expensive. -2
  • The MRQ is -109.265. Based on the earnings, the company is expensive. -2
  • The TTM is -66.296. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-192.684MRQ-109.265-83.419
MRQ-109.265TTM-66.296-42.969
TTM-66.296YOY-83.133+16.837
TTM-66.2965Y42.523-108.819
5Y42.52310Y30.387+12.136
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ALTEOGEN Inc:

  • The EOD is -115.300. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -65.383. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -66.784. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-115.300MRQ-65.383-49.917
MRQ-65.383TTM-66.784+1.401
TTM-66.784YOY-566.182+499.398
TTM-66.7845Y-171.624+104.840
5Y-171.62410Y-121.321-50.303
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alteogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 34.48 means the investor is paying ₩34.48 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of ALTEOGEN Inc:

  • The EOD is 60.798. Based on the equity, the company is expensive. -2
  • The MRQ is 34.477. Based on the equity, the company is expensive. -2
  • The TTM is 21.030. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD60.798MRQ34.477+26.321
MRQ34.477TTM21.030+13.447
TTM21.030YOY14.990+6.040
TTM21.0305Y25.643-4.613
5Y25.64310Y20.455+5.187
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ALTEOGEN Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---245.610-7.951-97%-85.825-65%10.969-2339%79.361-409%
Book Value Per Share--2857.0052986.935-4%3336.838-14%3403.445-16%3023.525-6%
Current Ratio--1.4354.118-65%11.352-87%11.145-87%9.478-85%
Debt To Asset Ratio--0.4230.410+3%0.387+9%0.288+47%0.192+121%
Debt To Equity Ratio--0.7310.697+5%0.631+16%0.447+64%0.295+147%
Dividend Per Share----0%-0%-0%-0%
Eps---225.369-16.347-93%-39.194-83%-18.842-92%-21.454-90%
Free Cash Flow Per Share---376.627-247.703-34%-163.467-57%-135.778-64%-140.422-63%
Free Cash Flow To Equity Per Share---376.627-233.006-38%-147.740-61%238.429-258%149.792-351%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.861+16%
Intrinsic Value_10Y_max---10442.330--------
Intrinsic Value_10Y_min---8938.421--------
Intrinsic Value_1Y_max---789.837--------
Intrinsic Value_1Y_min---775.661--------
Intrinsic Value_3Y_max---2568.667--------
Intrinsic Value_3Y_min---2448.315--------
Intrinsic Value_5Y_max---4583.245--------
Intrinsic Value_5Y_min---4237.220--------
Market Cap2358377010000.000-116%5097089350000.0003220617567875.000+58%2334007705849.900+118%2939954385451.880+73%1901600777649.983+168%
Net Profit Margin---0.522-0.272-48%-0.390-25%-0.306-41%-0.282-46%
Operating Margin----0.1390%-1.1920%-0.5590%-0.4580%
Operating Ratio--2.3012.107+9%1.174+96%1.384+66%1.456+58%
Pb Ratio60.798+43%34.47721.030+64%14.990+130%25.643+34%20.455+69%
Pe Ratio-192.684-76%-109.265-66.296-39%-83.133-24%42.523-357%30.387-460%
Price Per Share173700.000+43%98500.00062300.000+58%50324.984+96%83139.975+18%61443.036+60%
Price To Free Cash Flow Ratio-115.300-76%-65.383-66.784+2%-566.182+766%-171.624+162%-121.321+86%
Price To Total Gains Ratio-707.220-76%-401.043-263.913-34%-262.039-35%-425.171+6%-376.889-6%
Quick Ratio--0.9435.477-83%20.040-95%17.304-95%12.509-92%
Return On Assets---0.046-0.004-90%-0.008-82%-0.001-98%-0.007-85%
Return On Equity---0.079-0.010-87%-0.014-83%0.000-99%-0.009-89%
Total Gains Per Share---245.610-7.951-97%-85.825-65%10.969-2339%79.361-409%
Usd Book Value--103489214.038108036214.746-4%108815638.979-5%90137157.508+15%63743427.150+62%
Usd Book Value Change Per Share---0.172-0.006-97%-0.060-65%0.008-2339%0.056-409%
Usd Book Value Per Share--2.0002.091-4%2.336-14%2.382-16%2.116-6%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.158-0.011-93%-0.027-83%-0.013-92%-0.015-90%
Usd Free Cash Flow---13642543.138-8961384.107-34%-5755277.444-58%-4201092.156-69%-2957228.039-78%
Usd Free Cash Flow Per Share---0.264-0.173-34%-0.114-57%-0.095-64%-0.098-63%
Usd Free Cash Flow To Equity Per Share---0.264-0.163-38%-0.103-61%0.167-258%0.105-351%
Usd Market Cap1650863907.000-116%3567962545.0002254432297.513+58%1633805394.095+118%2057968069.816+73%1331120544.355+168%
Usd Price Per Share121.590+43%68.95043.610+58%35.227+96%58.198+18%43.010+60%
Usd Profit---8163542.100-590058.704-93%-1425550.530-83%-251679.885-97%-377173.566-95%
Usd Revenue--15645352.56216891512.552-7%5041110.288+210%8333759.453+88%5356656.197+192%
Usd Total Gains Per Share---0.172-0.006-97%-0.060-65%0.008-2339%0.056-409%
 EOD+3 -5MRQTTM+4 -28YOY+5 -275Y+7 -2510Y+7 -26

3.2. Fundamental Score

Let's check the fundamental score of ALTEOGEN Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-192.684
Price to Book Ratio (EOD)Between0-160.798
Net Profit Margin (MRQ)Greater than0-0.522
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.943
Current Ratio (MRQ)Greater than11.435
Debt to Asset Ratio (MRQ)Less than10.423
Debt to Equity Ratio (MRQ)Less than10.731
Return on Equity (MRQ)Greater than0.15-0.079
Return on Assets (MRQ)Greater than0.05-0.046
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of ALTEOGEN Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.176
Ma 20Greater thanMa 50174,210.000
Ma 50Greater thanMa 100168,920.000
Ma 100Greater thanMa 200124,943.000
OpenGreater thanClose177,700.000
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  27,075-19,5957,4801,3158,794-2,8645,930-10,300-4,370



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets256,099,995
Total Liabilities108,258,260
Total Stockholder Equity148,114,263
 As reported
Total Liabilities 108,258,260
Total Stockholder Equity+ 148,114,263
Total Assets = 256,099,995

Assets

Total Assets256,099,995
Total Current Assets144,075,803
Long-term Assets112,024,192
Total Current Assets
Cash And Cash Equivalents 30,199,529
Short-term Investments 80,407,571
Net Receivables 14,308,250
Inventory 1,068,359
Other Current Assets 0
Total Current Assets  (as reported)144,075,803
Total Current Assets  (calculated)125,983,709
+/- 18,092,093
Long-term Assets
Property Plant Equipment 19,288,474
Goodwill 112,983
Intangible Assets 89,217,856
Long-term Assets Other 0
Long-term Assets  (as reported)112,024,192
Long-term Assets  (calculated)108,619,313
+/- 3,404,879

Liabilities & Shareholders' Equity

Total Current Liabilities100,415,323
Long-term Liabilities7,842,937
Total Stockholder Equity148,114,263
Total Current Liabilities
Accounts payable 1,013,370
Other Current Liabilities 1
Total Current Liabilities  (as reported)100,415,323
Total Current Liabilities  (calculated)1,013,372
+/- 99,401,952
Long-term Liabilities
Long term Debt 1,249,257
Capital Lease Obligations Min Short Term Debt455,728
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)7,842,937
Long-term Liabilities  (calculated)1,704,985
+/- 6,137,952
Total Stockholder Equity
Retained Earnings 14,619,634
Total Stockholder Equity (as reported)148,114,263
Total Stockholder Equity (calculated)14,619,634
+/- 133,494,629
Other
Capital Stock26,505,914
Common Stock Shares Outstanding 51,747
Net Invested Capital 149,363,520
Net Working Capital 43,660,479
Property Plant and Equipment Gross 27,167,440



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
> Total Assets 
38,525,340
37,974,028
38,225,747
39,385,454
38,943,547
39,732,173
48,484,016
47,949,615
47,622,881
45,808,823
45,150,165
43,013,380
41,888,167
73,052,420
73,358,239
71,380,650
71,839,133
72,830,354
73,103,505
85,979,112
92,453,263
98,142,530
102,274,815
159,206,928
263,322,576
258,519,591
252,817,083
260,337,559
259,424,223
259,107,616
249,810,084
245,490,136
251,176,592
270,705,337
267,418,073
256,099,995
256,099,995267,418,073270,705,337251,176,592245,490,136249,810,084259,107,616259,424,223260,337,559252,817,083258,519,591263,322,576159,206,928102,274,81598,142,53092,453,26385,979,11273,103,50572,830,35471,839,13371,380,65073,358,23973,052,42041,888,16743,013,38045,150,16545,808,82347,622,88147,949,61548,484,01639,732,17338,943,54739,385,45438,225,74737,974,02838,525,340
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
36,398,740
35,183,110
35,670,223
34,575,603
65,652,328
59,172,359
58,257,365
58,684,306
57,286,139
55,955,769
65,209,452
70,935,168
75,170,720
79,125,413
137,906,946
241,227,338
226,839,455
220,989,236
212,216,375
204,448,866
189,823,443
172,038,936
139,327,307
133,052,072
149,339,953
139,389,625
144,075,803
144,075,803139,389,625149,339,953133,052,072139,327,307172,038,936189,823,443204,448,866212,216,375220,989,236226,839,455241,227,338137,906,94679,125,41375,170,72070,935,16865,209,45255,955,76957,286,13958,684,30658,257,36559,172,35965,652,32834,575,60335,670,22335,183,11036,398,740000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
7,016,308
5,234,708
5,229,129
5,452,426
16,727,293
9,652,398
8,915,116
8,334,995
5,989,220
10,066,369
4,413,478
10,984,724
6,723,949
6,560,263
38,922,455
9,385,128
11,680,997
17,792,559
10,539,626
0
0
0
45,828,917
48,888,996
26,800,958
22,330,916
30,199,529
30,199,52922,330,91626,800,95848,888,99645,828,91700010,539,62617,792,55911,680,9979,385,12838,922,4556,560,2636,723,94910,984,7244,413,47810,066,3695,989,2208,334,9958,915,1169,652,39816,727,2935,452,4265,229,1295,234,7087,016,308000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
27,708,000
27,711,000
27,200,877
24,603,877
44,606,138
44,609,138
42,600,000
44,600,000
41,600,000
35,020,780
0
0
0
69,830,144
94,734,000
226,036,000
207,300,000
194,950,560
191,464,960
168,444,610
159,755,167
151,935,242
81,710,440
69,855,549
94,552,624
87,240,603
80,407,571
80,407,57187,240,60394,552,62469,855,54981,710,440151,935,242159,755,167168,444,610191,464,960194,950,560207,300,000226,036,00094,734,00069,830,14400035,020,78041,600,00044,600,00042,600,00044,609,13844,606,13824,603,87727,200,87727,711,00027,708,000000000000
       Net Receivables 
1,574,947
133,289
700,117
0
98,239
1,149,002
760,411
1,374,020
2,398,817
834,050
1,163,859
1,332,438
2,620,592
2,211,154
2,289,891
4,631,906
3,689,664
5,090,233
2,515,045
1,836,992
1,590,084
11,262,562
1,651,492
2,692,677
3,222,233
3,720,547
4,827,254
5,930,779
4,746,336
2,648,345
3,611,096
8,551,421
3,328,260
5,988,294
6,042,516
14,308,250
14,308,2506,042,5165,988,2943,328,2608,551,4213,611,0962,648,3454,746,3365,930,7794,827,2543,720,5473,222,2332,692,6771,651,49211,262,5621,590,0841,836,9922,515,0455,090,2333,689,6644,631,9062,289,8912,211,1542,620,5921,332,4381,163,859834,0502,398,8171,374,020760,4111,149,00298,2390700,117133,2891,574,947
       Inventory 
0
0
0
0
0
393,204
196,989
195,069
173,882
155,214
276,089
216,147
453,717
147,813
589,113
475,788
354,560
857,992
1,071,352
881,574
884,731
1,529,329
557,164
459,663
503,230
991,546
947,114
1,048,885
1,852,132
2,172,150
2,020,084
1,574,690
1,862,367
1,634,633
1,507,919
1,068,359
1,068,3591,507,9191,634,6331,862,3671,574,6902,020,0842,172,1501,852,1321,048,885947,114991,546503,230459,663557,1641,529,329884,731881,5741,071,352857,992354,560475,788589,113147,813453,717216,147276,089155,214173,882195,069196,989393,20400000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,394,663
112,356,353
121,365,384
128,028,447
112,024,192
112,024,192128,028,447121,365,384112,356,353100,394,6630000000000000000000000000000000
       Property Plant Equipment 
445,403
3,794,654
4,128,868
4,095,358
4,116,891
4,104,051
4,205,472
4,729,396
4,657,539
4,584,428
4,727,222
5,026,119
5,083,118
5,027,841
11,819,892
11,706,630
11,721,687
14,095,581
15,614,971
19,191,524
19,936,860
21,367,391
21,478,422
19,483,926
20,025,265
29,583,550
30,296,417
29,599,713
29,649,455
31,372,728
33,388,845
27,243,344
26,953,609
26,211,609
26,159,917
19,288,474
19,288,47426,159,91726,211,60926,953,60927,243,34433,388,84531,372,72829,649,45529,599,71330,296,41729,583,55020,025,26519,483,92621,478,42221,367,39119,936,86019,191,52415,614,97114,095,58111,721,68711,706,63011,819,8925,027,8415,083,1185,026,1194,727,2224,584,4284,657,5394,729,3964,205,4724,104,0514,116,8914,095,3584,128,8683,794,654445,403
       Goodwill 
0
0
0
0
0
108,732
108,732
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983
112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983112,983108,732108,73200000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
249,989
279,988
309,987
339,985
359,984
359,984
371,384
374,384
376,645
379,645
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000379,645376,645374,384371,384359,984359,984339,985309,987279,988249,989000000000
       Intangible Assets 
124,425
145,590
152,604
180,898
199,550
541,039
568,673
582,563
568,297
584,141
533,325
600,695
480,475
473,900
479,645
507,725
521,145
530,747
599,886
630,514
646,511
638,408
686,022
907,452
922,549
986,823
993,176
11,236,149
17,714,671
30,667,367
38,631,250
47,187,478
59,484,976
70,611,651
78,368,804
89,217,856
89,217,85678,368,80470,611,65159,484,97647,187,47838,631,25030,667,36717,714,67111,236,149993,176986,823922,549907,452686,022638,408646,511630,514599,886530,747521,145507,725479,645473,900480,475600,695533,325584,141568,297582,563568,673541,039199,550180,898152,604145,590124,425
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
1
1
0
0110-10000000000000000000000000000000
> Total Liabilities 
868,644
728,895
658,114
834,623
897,285
1,912,310
1,623,210
2,720,918
1,819,620
1,789,692
2,141,042
3,168,348
3,045,655
35,363,935
5,352,084
4,684,231
5,248,284
9,433,369
9,446,948
15,996,663
19,697,110
20,848,736
19,942,317
28,043,244
38,296,771
81,530,204
82,543,672
123,605,224
97,856,824
100,874,998
96,565,402
96,731,185
110,029,553
102,895,630
106,866,754
108,258,260
108,258,260106,866,754102,895,630110,029,55396,731,18596,565,402100,874,99897,856,824123,605,22482,543,67281,530,20438,296,77128,043,24419,942,31720,848,73619,697,11015,996,6639,446,9489,433,3695,248,2844,684,2315,352,08435,363,9353,045,6553,168,3482,141,0421,789,6921,819,6202,720,9181,623,2101,912,310897,285834,623658,114728,895868,644
   > Total Current Liabilities 
545,172
348,949
268,322
413,195
453,978
1,548,159
1,287,109
2,223,977
1,368,687
1,332,916
1,742,687
2,695,155
2,533,087
34,782,401
3,192,750
2,476,848
2,983,013
5,822,773
6,853,213
9,763,660
5,452,323
11,817,877
11,150,975
11,066,474
10,063,056
13,276,217
11,333,754
12,353,465
15,575,493
18,942,545
14,765,240
13,132,246
24,663,303
18,125,126
99,364,085
100,415,323
100,415,32399,364,08518,125,12624,663,30313,132,24614,765,24018,942,54515,575,49312,353,46511,333,75413,276,21710,063,05611,066,47411,150,97511,817,8775,452,3239,763,6606,853,2135,822,7732,983,0132,476,8483,192,75034,782,4012,533,0872,695,1551,742,6871,332,9161,368,6872,223,9771,287,1091,548,159453,978413,195268,322348,949545,172
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
150,000
0
246,762
0
0
0
0
0
2,800,000
3,100,000
3,100,000
3,100,000
3,100,000
2,800,000
2,800,000
3,300,000
2,800,000
2,300,000
2,300,000
2,184,000
3,134,000
3,134,000
3,134,000
3,084,000
0
0
003,084,0003,134,0003,134,0003,134,0002,184,0002,300,0002,300,0002,800,0003,300,0002,800,0002,800,0003,100,0003,100,0003,100,0003,100,0002,800,00000000246,7620150,0000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
150,000
0
246,762
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,384,000
3,384,000
3,334,000
3,334,000
0
03,334,0003,334,0003,384,0003,384,000000000000000000000246,7620150,0000000000000
       Accounts payable 
0
0
0
0
41,469
1,104,820
833,261
1,507,054
903,942
860,679
1,088,520
1,297,085
1,147,650
0
2,115,101
1,619,165
2,102,253
2,378,600
1,617,911
1,026,376
523,469
1,205,984
334,940
440,242
752,911
1,970,098
2,330,858
1,411,483
1,810,522
484,987
842,308
159,514
108,202
279,860
520,441
1,013,370
1,013,370520,441279,860108,202159,514842,308484,9871,810,5221,411,4832,330,8581,970,098752,911440,242334,9401,205,984523,4691,026,3761,617,9112,378,6002,102,2531,619,1652,115,10101,147,6501,297,0851,088,520860,679903,9421,507,054833,2611,104,82041,4690000
       Other Current Liabilities 
545,172
348,949
268,322
413,195
412,509
252,356
453,848
716,923
464,745
472,237
504,167
1,398,070
1,138,675
34,782,401
949,390
290,551
423,094
2,414,126
2,222,160
4,937,864
1,515,451
7,054,405
7,290,926
7,191,656
5,853,164
7,265,001
5,579,570
7,896,382
10,739,931
15,469,418
10,082,464
9,048,710
20,606,976
13,952,648
0
1
1013,952,64820,606,9769,048,71010,082,46415,469,41810,739,9317,896,3825,579,5707,265,0015,853,1647,191,6567,290,9267,054,4051,515,4514,937,8642,222,1602,414,126423,094290,551949,39034,782,4011,138,6751,398,070504,167472,237464,745716,923453,848252,356412,509413,195268,322348,949545,172
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,799,609
7,548,096
7,511,639
7,502,670
7,842,937
7,842,9377,502,6707,511,6397,548,0965,799,6090000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,290,762
1,051,804
1,040,747
1,059,492
1,053,436
772,154
819,173
722,696
649,038
1,065,463
971,998
969,805
875,268
777,757
2,505,497
1,857,257
0
0
001,857,2572,505,497777,757875,268969,805971,9981,065,463649,038722,696819,173772,1541,053,4361,059,4921,040,7471,051,8041,290,762000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
-150,000
0
-246,762
0
0
0
0
0
-2,800,000
-3,100,000
-3,100,000
-3,100,000
-3,100,000
-2,800,000
-2,800,000
-3,300,000
-2,800,000
-2,300,000
-2,300,000
-2,184,000
-3,134,000
-2,878,824
-2,712,554
-2,742,953
450,142
455,728
455,728450,142-2,742,953-2,712,554-2,878,824-3,134,000-2,184,000-2,300,000-2,300,000-2,800,000-3,300,000-2,800,000-2,800,000-3,100,000-3,100,000-3,100,000-3,100,000-2,800,00000000-246,7620-150,0000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
2,119,636
2,246,562
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,173,982
16,616,650
29,544,361
37,440,725
45,870,388
58,156,078
69,196,601
0
0
0069,196,60158,156,07845,870,38837,440,72529,544,36116,616,65010,173,98200000000000000002,246,5622,119,636000000000
> Total Stockholder Equity
37,656,696
37,245,133
37,567,632
38,550,831
38,046,262
37,819,863
46,860,806
45,228,697
45,803,261
44,019,131
43,009,123
39,845,032
38,842,512
37,655,948
35,798,159
66,080,352
64,625,870
63,269,524
63,656,557
69,982,449
72,756,154
77,293,794
82,332,498
131,163,684
225,025,805
176,989,386
170,273,412
136,732,336
161,567,400
158,232,618
153,244,682
148,758,951
141,147,038
167,809,707
161,181,421
148,114,263
148,114,263161,181,421167,809,707141,147,038148,758,951153,244,682158,232,618161,567,400136,732,336170,273,412176,989,386225,025,805131,163,68482,332,49877,293,79472,756,15469,982,44963,656,55763,269,52464,625,87066,080,35235,798,15937,655,94838,842,51239,845,03243,009,12344,019,13145,803,26145,228,69746,860,80637,819,86338,046,26238,550,83137,567,63237,245,13337,656,696
   Common Stock
2,947,473
2,952,473
2,952,473
2,952,473
2,952,473
2,973,972
3,113,833
3,124,833
3,146,583
3,146,583
3,146,583
6,305,165
6,305,165
6,321,615
6,321,615
6,321,615
6,340,565
6,788,626
6,862,209
6,948,375
6,948,375
6,997,975
14,041,450
14,041,450
21,062,175
21,089,675
21,132,125
21,156,679
21,323,742
21,420,592
21,466,843
25,759,311
25,759,310
25,851,553
0
0
0025,851,55325,759,31025,759,31121,466,84321,420,59221,323,74221,156,67921,132,12521,089,67521,062,17514,041,45014,041,4506,997,9756,948,3756,948,3756,862,2096,788,6266,340,5656,321,6156,321,6156,321,6156,305,1656,305,1653,146,5833,146,5833,146,5833,124,8333,113,8332,973,9722,952,4732,952,4732,952,4732,952,4732,947,473
   Retained Earnings 
1,010,951
1,095,728
1,258,059
1,394,382
1,534,005
1,132,239
1,293,051
1,165,543
690,885
806,964
883,385
810,737
902,249
-8,655,727
-11,572,461
-12,533,768
-15,639,459
-17,230,081
-19,472,783
-13,238,281
-10,638,801
-8,190,438
-4,049,191
-14,207,879
-13,370,408
-20,160,200
-28,162,149
-32,938,795
-27,100,029
-32,745,261
-38,896,546
17,991,398
10,044,186
33,948,936
26,281,837
14,619,634
14,619,63426,281,83733,948,93610,044,18617,991,398-38,896,546-32,745,261-27,100,029-32,938,795-28,162,149-20,160,200-13,370,408-14,207,879-4,049,191-8,190,438-10,638,801-13,238,281-19,472,783-17,230,081-15,639,459-12,533,768-11,572,461-8,655,727902,249810,737883,385806,964690,8851,165,5431,293,0511,132,2391,534,0051,394,3821,258,0591,095,7281,010,951
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,826,927
74,825,058
74,825,058
76,623,951
70,451,783
129,072,001
214,314,788
173,330,048
174,907,108
145,627,620
164,042,806
166,289,621
167,208,469
101,659,106
101,659,106
103,679,685
0
0
00103,679,685101,659,106101,659,106167,208,469166,289,621164,042,806145,627,620174,907,108173,330,048214,314,788129,072,00170,451,78376,623,95174,825,05874,825,05874,826,927000000000000000000
   Treasury Stock00000000-793,980-793,980-793,98000000000000000-1,986,923-1,986,923-1,968,667-811,3050000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
806,964
883,385
810,737
902,249
799,932
875,972
946,261
1,031,289
1,078,472
1,355,025
871,542
1,045,767
1,286,550
1,312,701
1,580,664
1,928,987
2,433,580
2,353,235
2,743,087
3,139,288
3,106,074
3,310,451
3,675,912
4,011,211
4,670,373
0
0
004,670,3734,011,2113,675,9123,310,4513,106,0743,139,2882,743,0872,353,2352,433,5801,928,9871,580,6641,312,7011,286,5501,045,767871,5421,355,0251,078,4721,031,289946,261875,972799,932902,249810,737883,385806,964000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue96,522,929
Cost of Revenue-65,324,369
Gross Profit31,198,55931,198,559
 
Operating Income (+$)
Gross Profit31,198,559
Operating Expense-106,259,767
Operating Income-9,736,838-75,061,208
 
Operating Expense (+$)
Research Development25,305,766
Selling General Administrative5,020,642
Selling And Marketing Expenses0
Operating Expense106,259,76730,326,408
 
Net Interest Income (+$)
Interest Income5,191,585
Interest Expense-670,884
Other Finance Cost-0
Net Interest Income4,520,701
 
Pretax Income (+$)
Operating Income-9,736,838
Net Interest Income4,520,701
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,564,375-9,736,838
EBIT - interestExpense = -670,884
-3,371,764
-2,700,880
Interest Expense670,884
Earnings Before Interest and Taxes (EBIT)0-2,893,491
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,564,375
Tax Provision-17,834
Net Income From Continuing Ops-3,582,209-3,582,209
Net Income-3,371,764
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-4,520,701
 

Technical Analysis of Alteogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alteogen. The general trend of Alteogen is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alteogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ALTEOGEN Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 183,900 < 225,500 < 225,500.

The bearish price targets are: 158,900 > 156,200 > 100,300.

Tweet this
ALTEOGEN Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ALTEOGEN Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ALTEOGEN Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ALTEOGEN Inc. The current macd is -428.35049185.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alteogen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Alteogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Alteogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ALTEOGEN Inc Daily Moving Average Convergence/Divergence (MACD) ChartALTEOGEN Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ALTEOGEN Inc. The current adx is 18.63.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alteogen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
ALTEOGEN Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ALTEOGEN Inc. The current sar is 158,120.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ALTEOGEN Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ALTEOGEN Inc. The current rsi is 50.18. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
ALTEOGEN Inc Daily Relative Strength Index (RSI) ChartALTEOGEN Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ALTEOGEN Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alteogen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ALTEOGEN Inc Daily Stochastic Oscillator ChartALTEOGEN Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ALTEOGEN Inc. The current cci is 14.21.

ALTEOGEN Inc Daily Commodity Channel Index (CCI) ChartALTEOGEN Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ALTEOGEN Inc. The current cmo is -0.94145931.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ALTEOGEN Inc Daily Chande Momentum Oscillator (CMO) ChartALTEOGEN Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ALTEOGEN Inc. The current willr is -36.82310469.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Alteogen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ALTEOGEN Inc Daily Williams %R ChartALTEOGEN Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ALTEOGEN Inc.

ALTEOGEN Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ALTEOGEN Inc. The current atr is 12,850.

ALTEOGEN Inc Daily Average True Range (ATR) ChartALTEOGEN Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ALTEOGEN Inc. The current obv is 87,840,628.

ALTEOGEN Inc Daily On-Balance Volume (OBV) ChartALTEOGEN Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ALTEOGEN Inc. The current mfi is 54.93.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ALTEOGEN Inc Daily Money Flow Index (MFI) ChartALTEOGEN Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ALTEOGEN Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

ALTEOGEN Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ALTEOGEN Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.176
Ma 20Greater thanMa 50174,210.000
Ma 50Greater thanMa 100168,920.000
Ma 100Greater thanMa 200124,943.000
OpenGreater thanClose177,700.000
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Alteogen with someone you think should read this too:
  • Are you bullish or bearish on Alteogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alteogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ALTEOGEN Inc

I send you an email if I find something interesting about ALTEOGEN Inc.


Comments

How you think about this?

Leave a comment

Stay informed about ALTEOGEN Inc.

Receive notifications about ALTEOGEN Inc in your mailbox!